Cantargia AB (CHIX:CANTAS) Total Assets: kr267.8 Mil (As of Mar. 2026)


CHIX:CANTAS Cantargia AB CHIX:CANTAS
37 GF Score
Price kr4.17
! 2 Warning Signs
View Full Analysis

What is Cantargia AB Total Assets?

Cantargia AB CHIX:CANTAS 37 Total Assets is kr267.8 Mil as of Mar. 2026. GuruFocus rates CHIX:CANTAS with a GF Score™ of 37/100. The stock has 2 warning signs investors should review.

Cantargia AB's Total Assets for the quarter that ended in Mar. 2026 was kr267.8 Mil.

During the past 12 months, Cantargia AB's average Total Assets Growth Rate was -32.60% per year. During the past 3 years, the average Total Assets Growth Rate was -32.40% per year. During the past 5 years, the average Total Assets Growth Rate was 3.30% per year. During the past 10 years, the average Total Assets Growth Rate was 35.60% per year.

During the past 13 years, Cantargia AB's highest 3-Year average Total Assets Growth Rate was 107.20%. The lowest was -32.40%. And the median was 36.50%.

Total Assets is connected with ROA %. Cantargia AB's annualized ROA % for the quarter that ended in Mar. 2026 was -46.72%. Total Assets is also linked to Revenue through Asset Turnover. Cantargia AB's Asset Turnover for the quarter that ended in Mar. 2026 was 0.00.

Cantargia AB  (CHIX:CANTAs) Total Assets Explanation

Total Assets is connected with ROA %.

Cantargia AB's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=-131.88/( (296.66+267.838)/ 2 )
=-131.88/282.249
=-46.72 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Cantargia AB's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=0.508/( (296.66+267.838)/ 2 )
=0.508/282.249
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Cantargia AB Total Assets Related Terms

Cantargia AB Total Assets Historical Data

* Premium members only.

The historical data trend for Cantargia AB's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantargia AB Total Assets Chart

Cantargia AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 600.24 474.80 223.71 170.43 296.66

Cantargia AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 118.47 93.03 358.89 296.66 267.84
CHIX:CANTAS
37GF Score
Cantargia AB CHIX:CANTAS
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cantargia AB Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Cantargia AB's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=265.877+30.783
=296.7

Cantargia AB's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=233.951+33.887
=267.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of kr267.8 Mil mean?
Cantargia AB (CHIX:CANTAS) has a Total Assets of kr267.8 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Cantargia AB and its competitors.
Is Cantargia AB's Total Assets too high?
Cantargia AB's current Total Assets is kr267.8 Mil. Overall, Cantargia AB has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Cantargia AB's Total Assets compare to VRTX and REGN?
Cantargia AB's Total Assets of kr267.8 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Cantargia AB and its competitors. Cantargia AB's current Total Assets is kr267.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantargia AB stock overvalued right now?
Cantargia AB (CHIX:CANTAS) has a current Total Assets of kr267.8 Mil. The current Total Assets is kr267.8 Mil. Cantargia AB's overall GF Score™ is 37/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Cantargia AB (CHIX:CANTAS), the current Total Assets is kr267.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cantargia AB Business Description

Other Exchanges CANTA:Sweden7V3:Germany
Address Scheelevagen 27, Lund, SWE, 223 63
Cantargia AB is a Swedish biotech company that develops targeted antibody-based drugs for cancer as well as autoimmune and inflammatory diseases. It has developed specific antibodies against IL1RAP to treat serious, life-threatening diseases. The company's development programme includes the candidate drugs nadunolimab (CAN04) and CAN10, both in the clinical development stage, which were latter acquired by Otsuka Pharmaceutical in 2025. In addition, the company is also developing a a pre-clinical project CAN14, derived from antibody platform CANxx. Geographically, the company's revenues have been generated in the markets of Japan and United States.
37GF Score

Get the complete analysis for CHIX:CANTAS

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr4.17
Price